perindopril has been researched along with Vascular Diseases in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chalmers, J; Cooper, ME; Hamet, P; Harrap, S; Jun, M; Kim, H; Mancia, G; Marre, M; Poulter, NR; Rebholz, CM; Selvin, E; Wang, D; Woodward, M; Zoungas, S | 1 |
| Chalmers, J; Colagiuri, S; Cooper, ME; DeVries, JH; Grobbee, DE; Hamet, P; Li, Q; Mancia, G; Marre, M; van Steen, SC; Williams, B; Woodward, M | 1 |
| Akkerhuis, KM; Arima, H; Bertrand, M; Boersma, E; Brugts, JJ; Caliskan, K; Chalmers, J; DiNicolantonio, J; Ferrari, R; Fox, K; MacMahon, S; Mourad, JJ; Remme, W; Simoons, ML; Zijlstra, F | 1 |
| Liu, W; Wu, S; Zhou, Y | 1 |
| Bertrand, M; Boersma, E; Brugts, JJ; Chalmers, J; Ferrari, R; Fox, K; MacMahon, S; Ninomiya, T; Remme, WJ; Simoons, ML | 1 |
| Anderson, C; Arima, H; Chalmers, J; Liu, L; Macmahon, S; Neal, B; Omae, T; Rodgers, A; Tzourio, C; Woodward, M | 1 |
| Chalmers, J | 1 |
| Cambien, F; Chalmers, J; Chapman, N; Colman, S; Harrap, SB; Leguennec, S; MacMahon, S; Neal, B; Ohkubo, T; Poirier, O; Raoux, S; Tzourio, C; Woodward, M | 1 |
| Anderson, C; Arima, H; Bousser, MG; Butcher, K; Chalmers, J; Lees, KR; MacMahon, S; Omae, T; Reid, JL; Tzourio, C; Woodward, M | 1 |
| Waeber, B | 1 |
| Bakris, GL; Duka, I | 1 |
| Beevers, DG; Lip, GY | 1 |
2 review(s) available for perindopril and Vascular Diseases
| Article | Year |
|---|---|
Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diuretics; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Vascular Diseases | 2006 |
ACE inhibitors in vascular disease: some PROGRESS, more HOPE.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Female; Forecasting; Humans; Hypertension; Male; Middle Aged; Perindopril; Primary Prevention; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Stroke; Treatment Outcome; United Kingdom; Vascular Diseases | 2001 |
5 trial(s) available for perindopril and Vascular Diseases
| Article | Year |
|---|---|
Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial.
Topics: Aged; Antihypertensive Agents; beta 2-Microglobulin; Biomarkers; Cause of Death; Creatinine; Cystatin C; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Indapamide; Male; Middle Aged; Outcome Assessment, Health Care; Perindopril; Risk Factors; Vascular Diseases | 2020 |
Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
Topics: Aged; Antihypertensive Agents; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Combinations; Female; Gliclazide; Glycosylation; Hemoglobins; Humans; Hypoglycemic Agents; Indapamide; Male; Microcirculation; Middle Aged; Perindopril; Proportional Hazards Models; Risk; Treatment Outcome; Vascular Diseases | 2018 |
The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease.
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Cough; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Perindopril; Predictive Value of Tests; Sex Factors; Vascular Diseases | 2014 |
Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial.
Topics: Aged; Antihypertensive Agents; Asian People; Blood Pressure; Cerebrovascular Disorders; Coronary Disease; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Perindopril; Risk Factors; Stroke; Vascular Diseases; White People | 2010 |
[ADVANCE study: objectives, design and current status].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Vascular Diseases | 2003 |
5 other study(ies) available for perindopril and Vascular Diseases
| Article | Year |
|---|---|
Spontaneous coronary artery dissection in the presence of myocardial bridge causing myocardial infarction: an insight into mechanism.
Topics: Adult; Aspirin; Atorvastatin; Clopidogrel; Coronary Angiography; Coronary Vessel Anomalies; Female; Humans; Myocardial Bridging; Myocardial Infarction; Perindopril; Ticlopidine; Treatment Outcome; Vascular Diseases | 2016 |
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cause of Death; Diabetic Angiopathies; Drug Therapy, Combination; Female; Humans; Indapamide; Male; Middle Aged; Perindopril; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Stroke Volume; Treatment Outcome; Vascular Diseases | 2009 |
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cognition Disorders; Dementia; Female; Genotype; Humans; Hypertension; Male; Middle Aged; Mutagenesis, Insertional; Peptidyl-Dipeptidase A; Perindopril; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Risk Factors; Sequence Deletion; Statistics as Topic; Stroke; Survival Analysis; Time Factors; Treatment Outcome; Vascular Diseases | 2003 |
Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Cerebral Hemorrhage; Coronary Disease; Female; Humans; Male; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Risk Reduction Behavior; Stroke; Vascular Diseases | 2006 |
Should all patients with type 2 diabetes receive initial combination therapy: an assessment of the ADVANCE trial.
Topics: Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Vascular Diseases | 2007 |